ALIBABA HEALTH INF revenue breakdown overview

ALIBABA HEALTH INF revenue for the last year amounted to 3.38 B CHF, the most of which — 3.14 B CHF — came from its highest performing source at the moment, Pharmaceutical Direct Sales, the year earlier bringing 2.56 B CHF. The greatest contribution to the revenue figure was made by China — last year it brought ALIBABA HEALTH INF 3.39 B CHF, and the year before that — 2.88 B CHF.